These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 1388329)
1. Effects of calcitonin gene-related peptide on cardiac contractility, coronary hemodynamics and myocardial energetics in idiopathic dilated cardiomyopathy. Dubois-Randé JL; Merlet P; Benvenuti C; Sediame S; Macquin-Mavier I; Chabrier E; Braquet P; Castaigne A; Adnot S Am J Cardiol; 1992 Oct; 70(9):906-12. PubMed ID: 1388329 [TBL] [Abstract][Full Text] [Related]
2. Coronary vasodilating action of dobutamine in patients with idiopathic dilated cardiomyopathy. Dubois-Randé JL; Merlet P; Duval-Moulin AM; Adnot S; Saal JP; Chabrier E; Castaigne A; Geschwind H Am Heart J; 1993 May; 125(5 Pt 1):1329-36. PubMed ID: 8480585 [TBL] [Abstract][Full Text] [Related]
3. Hemodynamic response to intracoronary infusion of atrial natriuretic factor in patients with normal or altered left ventricular function. Dubois-Rande JL; Adnot S; Benvenuti C; Merlet P; Hittinger L; Sediame S; Chabrier E; Braquet P; Castaigne A J Cardiovasc Pharmacol; 1991 Apr; 17(4):608-14. PubMed ID: 1711628 [TBL] [Abstract][Full Text] [Related]
4. Direct myocardial and coronary effects of enalaprilat in patients with dilated cardiomyopathy: assessment by a bilateral intracoronary infusion technique. Foult JM; Tavolaro O; Antony I; Nitenberg A Circulation; 1988 Feb; 77(2):337-44. PubMed ID: 2827913 [TBL] [Abstract][Full Text] [Related]
5. Myocardial energetics and efficiency in patients with idiopathic cardiomyopathy: response to dobutamine and amrinone. Sundram P; Reddy HK; McElroy PA; Janicki JS; Weber KT Am Heart J; 1990 Apr; 119(4):891-8. PubMed ID: 2321508 [TBL] [Abstract][Full Text] [Related]
6. Cardiac energetics after intravenous enoximone in idiopathic dilated cardiomyopathy. Heiss HW; Hasenfuss G; Holubarsch C; Meinertz T; Just H Am J Cardiol; 1987 Aug; 60(5):53C-56C. PubMed ID: 2956869 [TBL] [Abstract][Full Text] [Related]
7. Effects of low-dose dobutamine on coronary hemodynamics, myocardial metabolism, and anginal threshold in patients with coronary artery disease. Pacold I; Kleinman B; Gunnar R; Loeb HS Circulation; 1983 Nov; 68(5):1044-50. PubMed ID: 6616788 [TBL] [Abstract][Full Text] [Related]
8. Hemodynamic, renal and endocrine effects of atrial natriuretic peptide infusion in severe heart failure. Molina CR; Fowler MB; McCrory S; Peterson C; Myers BD; Schroeder JS; Murad F J Am Coll Cardiol; 1988 Jul; 12(1):175-86. PubMed ID: 2967855 [TBL] [Abstract][Full Text] [Related]
9. Effects of commonly used inotropes on myocardial function and oxygen consumption under constant ventricular loading conditions. DeWitt ES; Black KJ; Thiagarajan RR; DiNardo JA; Colan SD; McGowan FX; Kheir JN J Appl Physiol (1985); 2016 Jul; 121(1):7-14. PubMed ID: 27150829 [TBL] [Abstract][Full Text] [Related]
10. Influence of UDCG-115 on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy. Hasenfuss G; Holubarsch C; Heiss HW; Just H Am Heart J; 1989 Sep; 118(3):512-9. PubMed ID: 2773772 [TBL] [Abstract][Full Text] [Related]
11. [Changes in PTCA. A model of ischemia in humans]. Prachar H Acta Med Austriaca Suppl; 1991; 42():1-35. PubMed ID: 1830715 [TBL] [Abstract][Full Text] [Related]
12. Effects of atrial natriuretic factor on coronary hemodynamics and myocardial energetics in patients with heart failure. Herrmann HC; Palacios IF; Dec GW; Scheer JM; Fifer MA Am Heart J; 1988 Jun; 115(6):1232-8. PubMed ID: 2967626 [TBL] [Abstract][Full Text] [Related]
13. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure]. La Vecchia L; Bottero M; Centofante P; Bedogni F; Ometto R; Cera A; Fortunato A G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168 [TBL] [Abstract][Full Text] [Related]
14. Effects of alpha human atrial natriuretic polypeptide on the systemic hemodynamics and coronary circulation in patients with ischemic heart disease. Serizawa T; Kohmoto O; Iizuka M; Hirata Y; Matsuoka H; Ohya T; Kimura Y; Sato H; Takahashi T; Masuo M Jpn Circ J; 1988 Oct; 52(10):1107-13. PubMed ID: 2974890 [TBL] [Abstract][Full Text] [Related]
15. Effects of dobutamine on left ventricular performance and myocardial metabolic demands in patients with ischemic heart disease. Côté P; Bourassa MG; Tubau JF; Enjalbert M; Vandormael M Clin Cardiol; 1984 Jan; 7(1):14-22. PubMed ID: 6705283 [TBL] [Abstract][Full Text] [Related]
16. Relationship among neuropeptide Y, catecholamines and haemodynamics in congestive heart failure. Dubois-Randé JL; Comoy E; Merlet P; Benvenuti C; Carville C; Hittinger L; Macquin-Mavier I; Bohuon C; Castaigne A Eur Heart J; 1992 Sep; 13(9):1233-8. PubMed ID: 1396834 [TBL] [Abstract][Full Text] [Related]
17. Cardiovascular profile of 5 novel nitrate-esters: a comparative study with nitroglycerin in pigs with and without left ventricular dysfunction. van Woerkens LJ; van der Giessen WJ; Verdouw PD Br J Pharmacol; 1991 Sep; 104(1):7-14. PubMed ID: 1786521 [TBL] [Abstract][Full Text] [Related]
18. Effects of atrial natriuretic peptide on myocardial contractile and diastolic function in patients with heart failure. Semigran MJ; Aroney CN; Herrmann HC; Dec GW; Boucher CA; Fifer MA J Am Coll Cardiol; 1992 Jul; 20(1):98-106. PubMed ID: 1535081 [TBL] [Abstract][Full Text] [Related]
19. Dobutamine enhances cardiodepressant effects of receptor-mediated coronary endothelial stimulation. Bartunek J; Shah AM; Vanderheyden M; Paulus WJ Circulation; 1997 Jan; 95(1):90-6. PubMed ID: 8994422 [TBL] [Abstract][Full Text] [Related]
20. Conditioning effects of chronic infusions of dobutamine. Comparison with exercise training. Liang C; Tuttle RR; Hood WB; Gavras H J Clin Invest; 1979 Aug; 64(2):613-9. PubMed ID: 457872 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]